摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4'-(4-methoxyphenyl)-3-[(4-methoxyphenyl)methylidene]-1'-methyl-1"-[(1-piperidinyl)methylene]-dispiro[cyclohexane-1,3'-pyrrolidine-2',3"-[3H]indole]-2,2"(1"H)-dione

中文名称
——
中文别名
——
英文名称
4'-(4-methoxyphenyl)-3-[(4-methoxyphenyl)methylidene]-1'-methyl-1"-[(1-piperidinyl)methylene]-dispiro[cyclohexane-1,3'-pyrrolidine-2',3"-[3H]indole]-2,2"(1"H)-dione
英文别名
——
4'-(4-methoxyphenyl)-3-[(4-methoxyphenyl)methylidene]-1'-methyl-1"-[(1-piperidinyl)methylene]-dispiro[cyclohexane-1,3'-pyrrolidine-2',3"-[3H]indole]-2,2"(1"H)-dione化学式
CAS
——
化学式
C38H43N3O4
mdl
——
分子量
605.777
InChiKey
BLWXQMFGFDPBKH-WJBJUIIOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    45
  • 可旋转键数:
    6
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    62.3
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    肌氨酸(2E,6E)-2,6-bis(4-methoxybenzylidene)cyclohexanone1-(哌啶-1-基甲基)吲哚-2,3-二酮乙醇 为溶剂, 反应 20.0h, 以60%的产率得到4'-(4-methoxyphenyl)-3-[(4-methoxyphenyl)methylidene]-1'-methyl-1"-[(1-piperidinyl)methylene]-dispiro[cyclohexane-1,3'-pyrrolidine-2',3"-[3H]indole]-2,2"(1"H)-dione
    参考文献:
    名称:
    Design, synthesis and QSAR studies of dispiroindole derivatives as new antiproliferative agents
    摘要:
    A variety of 4'-ary1-3-(arylmethylidene)-1 ''-[(cyclic-amino)methylene]-1'-methyl-dispiro[cyclohexane-1,3'-pyrrolidine-2',3 ''-[3H]indole]-2,2 ''(1"H)-diones 4a-u were prepared via reaction of 2E,6E-bis(arylidene)-1-cyclohexanones 1a-i with azomethine ylides, generated in situ via a decarboxylative condensation of isatins 2a-c and sarcosine (3). Single crystal X-ray study of 4a, revealed structural and stereochemical features of these derivatives. While most of the synthesized compounds exhibit mild antitumor properties when tested against various human tumor cell lines (HEPG2 "liver", HELA "cervical" and PD "prostate" cancers), three of them, 4d and 4p (active against HEPG2), and compound 4g (active against HELA), demonstrated higher activities, that were close or even higher than that of the reference standard Doxorubicin. QSAR studies revealed good predictive and statistically significant 3 descriptor models (r(2) = 0.903-0.812, r(adjusted)(2) = 0.855-0.672, r(prediction)(2) = 0.773-0.605). (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.07.035
点击查看最新优质反应信息

文献信息

  • Design, synthesis and QSAR studies of dispiroindole derivatives as new antiproliferative agents
    作者:Riham F. George、Nasser S.M. Ismail、Jacek Stawinski、Adel S. Girgis
    DOI:10.1016/j.ejmech.2013.07.035
    日期:2013.10
    A variety of 4'-ary1-3-(arylmethylidene)-1 ''-[(cyclic-amino)methylene]-1'-methyl-dispiro[cyclohexane-1,3'-pyrrolidine-2',3 ''-[3H]indole]-2,2 ''(1"H)-diones 4a-u were prepared via reaction of 2E,6E-bis(arylidene)-1-cyclohexanones 1a-i with azomethine ylides, generated in situ via a decarboxylative condensation of isatins 2a-c and sarcosine (3). Single crystal X-ray study of 4a, revealed structural and stereochemical features of these derivatives. While most of the synthesized compounds exhibit mild antitumor properties when tested against various human tumor cell lines (HEPG2 "liver", HELA "cervical" and PD "prostate" cancers), three of them, 4d and 4p (active against HEPG2), and compound 4g (active against HELA), demonstrated higher activities, that were close or even higher than that of the reference standard Doxorubicin. QSAR studies revealed good predictive and statistically significant 3 descriptor models (r(2) = 0.903-0.812, r(adjusted)(2) = 0.855-0.672, r(prediction)(2) = 0.773-0.605). (C) 2013 Elsevier Masson SAS. All rights reserved.
查看更多